The EU ombudsman, Emily O'Reilly, issued a formal recommendation telling von der Leyen's office to search for and hand over the texts under a freedom of information request lodged by a journalist.
In April last year, the New York Times revealed that EU Commission President Ursula von der Leyen and Pfizer CEO Albert Bourla had exchanged text messages and calls about vaccine procurements for EU countries.
The European Commission chief used 'personal diplomacy' to secure the deal for 1.8billion Pfizer vaccines via texts with the CEO, the paper revealed.
Journalist Alexander Fanta of news site netzpolitik.org then asked the Commission for access to the text messages and other documents, but the executive branch did not provide them.
The commission rebuffed the freedom-of-information request, refusing to say whether the texts existed - even though von der Leyen had referred to them herself in a media interview.
According to the ombudsman's inquiry, the Commission did not clearly ask von der Leyen's cabinet to look for the text messages. Instead, the Commission said the only information they had was an email, a letter and a press release.
O'Reilly said:
"This falls short of reasonable expectations of transparency and administrative standards in the Commission. When it comes to the right of public access to EU documents, it is the content of the document that matters and not the device or form. If text messages concern EU policies and decisions, they should be treated as EU documents."The ombudsman said the commission should ask von der Leyen's office to again look for the texts, and if it found them
"the Commission should assess whether public access can be granted to them' in line with EU rules. The EU administration needs to update its document recording practices to reflect this reality."The Commission argued:
"a text message or another type of instant messaging is by its nature a short-lived document which does not contain in principle important information concerning matters relating to policies, activities and decisions of the Commission' and that 'the Commission record-keeping policy would in principle exclude instant messaging. To date, it has not recorded any text messages in its document management system."But O'Reilly rejected this argument, saying that texts fall within the Commission's definition of a document.
Von der Leyen's Commission spearheaded the pre-purchase of Covid vaccines for the 27 EU countries.
More than half the doses the commission has bought or optioned are sourced from BioNTech-Pfizer, making it by far the biggest supplier to the bloc's inoculation efforts.
The commission refuses to divulge key aspects of its contracts with Covid vaccine suppliers, notably on pricing, citing commercial confidentiality.
Last year, there was a mad scramble to secure vaccines, with the EU and the UK coming to blows over contracts with the major pharmaceutical companies.
While Britain was able to get on top of their world-beating vaccine rollout and administer 20 million jabs within a few weeks of the Pfizer and AstraZeneca vaccines being approved, EU leaders lagged behind in implementing a vaccine plan.
Brussels chiefs were furious at AstraZeneca for promising the UK first deliveries of its vaccine supplies, claiming it has reneged on its deal with the bloc.
Countries such as France and Germany then went back-and-forth about whether to rollout the AstraZeneca jab, which sowed doubts among the public and led to a low uptake of the vaccines.
Michel Barnier, 70, later said that ideology, red tape and an aversion to risk-taking led Europe to bungle its early vaccination drive.
Although the European Public Prosecutor's Office (EPPO) has not taken any action, for easily foreseeable reasons, we continue to present striking information relating to the Pfizer-Ursula file. Official information, verified. No bedtime stories. The results of this investigation are explosive.
These results unequivocally show the dirty combination of the best politicians in the EU and the Big Pharma mafia, in the midst of the COVID-19 pandemic. They mocked the lives, health and freedoms of hundreds of millions of people terrorized by a false propaganda system. They pushed our limits with billions of vaccines (far more than we needed), just out of their hunger for profit. The big pot is approximately $ 36 billion. This translates into 1.8 billion doses of Pfizer vaccine, negotiated by the head of the European Union with the manager of the pharmaceutical company, Albert Bourla, in a totally non-transparent way, as was mentioned in my previous articles, which are still to be find on the site of Mediafax.ro (press agency), if there are no "technical problems".
I'll tell you about it briefly, in the first part, with fewer numbers, but enough references and names of the protagonists, as shown by direct and indirect testimonies, put together. Chief Prosecutor Kovesi's option to take this investigation to the next level remains. To verify bank accounts, the flow of money between companies, to request FBI support in New York and Brussels and to convict the perpetrators, in the same way that it has done with the many prominent politicians in Romania. He just needs the will to do it. Pfizer is not susceptible to its first infringement.
It is mentioned in many files, some even of a criminal nature, without for the moment no one has pleaded guilty. American prosecutors placed him under direct observation and yet did not complete the case and did not convict any executive directors involved. The key to the $ 36 billion business is Ursula von der Leyen's husband. Until the outbreak of the COVID-19 pandemic and long after her debut, no one has ever heard of Doctor Heiko von der Leyen, husband of the First Lady of Brussels. In other words, he is the spouse of the head of the European government. The Leyens have lived near Hanover (Germany) since 2007, on the property Heiko inherited from her parents. They have seven children and a grandson.And now, let's remember our memory. The pandemic debuted in Romania in March 2020. A few months later, in December 2020, a relatively unknown German doctor joins the board of directors of a large and very powerful pharmaceutical company in the United States. No, it's not Pfizer.
It would have been too simple and too flashy. Dr. Heiko was transferred across the ocean "for service reasons" to exactly a company with a proven track record in MARN technology. This is Orgenesis Inc. At that point, the Orgenesis experts were concerned about cancer treatments and experiments.But suddenly an opportunity arose: the pandemic! Thus, the good folks at Pfizer immediately sneezed at the mega-business on the horizon. They've been experts at doing it, haven't they? The link between the two American companies, Pfizer and Orgenesis, is more than evident. There are mutual funds in their property listed on the New York Stock Exchange. I will elaborate on this later.We still don't know if ownership changed with the abrupt arrival of Heiko von der Leyen from Germany (for negotiations?) Or has always been the case. We will find out. As a matter of fact, though, Ursula's husband ended up on the board of Orgenesis like a square peg in a round hole. Almost nothing in his biography recommended him for the prime position of "medical director". In other words, one of the executives paid a minimum of $ 1 million a year.
The coincidence was surprising. Why Heiko joined Orgenesis' board of directors exactly in December 2020 remains an open question that unravels the mystery of the whole thing. It is worth noting that the first vaccine in Romania was taken in the same month. A medical nurse took it. Everything followed a fast forward path afterwards.In the spring of 2021, immediately after Heiko's arrival in Orgenesis, intense political negotiations were underway. His wife exchanged text messages and calls with both Pfizer's CEO and her husband, who is in Pfizer's immediate vicinity (basically, a couple of blocks away). I stated in my previous articles on Mediafax that Ms Ursula von der Leyen's text messages and calls suddenly disappeared from her phone, much to the amazement of Ombudsman Emily O'Reilly (a kind of people's advocate, however, at the level European).Still, it wasn't the first time that Ursula von der Leyen erased all traces of her from her phone, in a way that she surpassed Harry Potter's abilities. The big news arrived on May 8, 2021. The Europeans were relieved. Ursula von der Leyen has closed the deal with Pfizer for 1.8 billion doses of the vaccine, more or less. No amount per dose was mentioned because such transparency was not necessary, of course, especially when a dollar more or less means a total of $ 1.8 billion, more or less.And this is money from our pockets, Romanians, Bulgarians and Hungarians. Vaccinated or not, it didn't matter at all. In the absence of official statistics and numbers, the business is estimated to be worth around $ 36 billion, which equates to around $ 20 per dose. Since "maximum" transparency was in place, indirect evidence follows. This is based only on facts, numbers and official communications that I have managed to collect as of now, in the absence of any "heroin anti-corruption" initiative, Chief Prosecutor Laura Codruta Kovesi with a value of $ 38 billion, such contracts they bear "performance fees".
For the Romanian mayors, since the amount values are very low, we refer to percentage commissions of 10-15. Brussels uses small commissions but derived from very large values. The profit is also gigantic. Personally, I had some difficulty calculating 2% out of 38 billion. It becomes a "performance fee" of $ 760 million, to be exact.Now, if you were to ask Sorin Ovidiu Vantu, the founder of the National Investment Fund, he would tell you that the respective amount (or even doubled, as there is always more room) was transferred quickly, well and elegantly from the Pfizer profit. to the Orgenesis, as a "performance bonus" for the lady's husband, the medical director recently landed for negotiations.However, this could only happen if prosecutor Kovesi could verify some bank accounts in collaboration with the FBI, American and European prosecutors.
And, of course, if the former head of the NAD (National Anticorruption Directorate) has little of her aura of incorruption that drew her to Brussels, into the entourage of Ursula von der Leyen. I offer to provide you with the entire file with official information gathered from reliable sources and connections, in case you do not have enough employees. All free of charge, with the sole reimbursement of the cost of the DHL service. Verified data, no pandemic fake news, promoted by who knows what dark sites.Precisely because reading such a file can confuse readers, I decided to present it as a serial story. Here you have the big picture, the plot. I'll come back with the details: names, companies, significant shareholders, biographies, direct and indirect links. Ms. Kovesi knows where to find me, in the provincial city of Iasi, somewhere in the north-east of Romania. Very close to the Russians, as the hashtag guys would say.I can only hope that he takes a little break from chasing Bulgarian car traffickers and focuses on more serious issues, such as genuine European corruption. In the next few days you will witness a scandalous network, because politicians, hand in hand with the big pharmaceutical industry, have taken advantage of this pandemic to get rich on the shoulders and pockets of all of us Europeans.
But the most visible are the significant joint shareholders of Orgenesis and Pfizer. According to the New York Stock Exchange, they would be as follows: Orgenesi The Vanguard Group, Inc. 3.77% SSgA Funds Management, Inc. 0.34% Geode Capital Management LLC 0.81% Total - 4.92% Pfizer The Vanguard Group , Inc. 7.78% SSgA Funds Management, Inc. 4.97% Geode Capital Management LLC 1.78% Total - 14.53% So, if we're talking about investors, the two US mega-firms are related. It has not been possible, for now, to verify the connections between the people on the boards of the companies. Too little time, too few resources. Perhaps the European Public Prosecutor's Office, the FBI and the American justice system will help, although I would not bet too much on it. Who would benefit from it, after all?The Vanguard investment fund stands out. As of March 2021, Vanguard owns the majority of shares in another giant fund, BlackRock. The two large financial groups control almost everything, globally. Basically, they have Big Pharma in their pocket.
In February 2020 they were among the largest shareholders of the giant GlaxoSmithKline (GSK), respectively 7% and 3.5% of the total. It is almost impossible to find out all the owners of the shares of the Vanguard fund.But some names stand out, according to official stock exchange sources: Rothschild Investment Corp., Edmond De Rothschild Holding, several families such as Orsini from Italy, Bush from the United States, du Pont, Morgan, Vanderbilt, Rockefeller. Including the royal family in the UK. The two investment funds mentioned own approximately 90% of the media institutions in the United States.And now let's get back to the thread of history. In March 2020, the pandemic began at full speed, with armored vehicles on the street, even though the hospitals in Romania were empty. Or at most full of asymptomatic people. The Pfizer company, linked to Orgenesis on the side of scientific and clinical tests, patented the mRNA project together with the Germans of BioNTech (also excellent on the production side), then put the goods on sale.
Great demand, single supplier, maximum urgency. Nobody was surprised by the price of 15-18 euros per dose, when people fell on the street, killed by the invisible virus. From here on, the question of maximizing profit arose, as in any mega-company: how do you earn so much money with minimal effort?One of the solutions seems to have been to co-opt Heiko van der Leyen on the board of directors of Oregensis (closely related to Pfizer from a testing point of view, as we have seen).The key event occurred in December 2020, just eight months after the pandemic began and with just a few months before Ursula signed the $ 36 billion contract with Pfizer. But until we could talk about mega-contracts and other "performance bonuses", we all saw a spectacular jump in base salary, from around $ 300,000 a year (in Germany) to over $ 1.5 million. (to the Orgenesis Company). And let's be clear: only the salary as a director, no other bonuses. Perhaps Ursula was very happy when she heard the news.However, they have seven children and a grandson to raise, at home in Germany, near Hanover. We all know from the last episode (and from the very few articles that have appeared in the media) how the Ursula-Bourla (Pfizer) negotiation went: extremely opaque.
Furthermore, it seems that the Brussels boss has committed it again: according to reports from the reporters of the New York Times, he would have erased his traces from his mobile phone. Ursula's messages and calls suddenly disappeared, much to the amazement of Ombudsman Emily O’Reilly (a kind of people's advocate, but at the level of the European Union).The European Commission has made it clear that it has no correspondence between Ursula and Bourla (head of Pfizer). SMS and other short messages are inherently "short-lived and, in principle, do not contain important information about the Commission's policy, activities or decisions," said Commission Secretary-General Ilze Juhansone. How would that sound, why should we look into Ursula's phone? Don't we have any other work to do?It is not written on her phone which fines Poland and Hungary will still pay, for the simple reason that they are not in line with Brussels policies. A journalist had the courage to ask, however, if Ursula's messages to Bourla had been deleted, or if there were others not archived or if the European commissioners were aware of them. The question remained unanswered.
An EC spokesperson confirmed to the press that short messages are not recorded in the Ares system (the EU's internal archiving program). In any case, at the moment "there are no technical possibilities for recording short messages". It should be emphasized that the phenomenon is in strong contradiction with the Commission's Internal Regulation adopted in 2015. According to them, SMS and similar messages should be copied into an e-mail, scanned or otherwise recorded.Independent media wanted to know more details about the vaccine business. Pursuant to regulation no. 1049/2001, another journalist asked the European Commission to disclose all communications between Bourla and Ursula, but "the request was rejected by the General Secretariat of the European Commission". And since the European Public Prosecutor's Office has not notified itself (what sense would it make, right?), No one can know, for now, under what conditions the Pfizer-EU negotiation for the 1.8 billion doses of the vaccine was conducted.In other words, it's all covered up, as I said earlier in a recent "missing" article. In fact, on 24 April 2021, shortly before the signing of the negotiated contract with Bourla, Ursula visited the Pfizer / BioNtech plant in Germany. Obviously, to ensure that production runs at full capacity and that the vaccines arrive on time at European airports.